Alliance for Pandemic Preparedness
February 26, 2021
SARS-CoV-2 Viremia Is Associated with Distinct Proteomic Pathways and Predicts COVID-19 Outcomes
Category: Article Summary
Topic: Vaccines and Immunity
Keywords (Tags): clinical characteristics
- [pre-print; not peer-reviewed] Levels of plasma SARS-CoV-2 viremia at the time of presentation to a hospital’s emergency department predicted both disease severity and mortality within 28 days. Viremia (defined as presence of SARS-CoV-2 RNA in plasma samples) was present in around 40% of participants and was associated with a dose-dependent effect on clinical outcome.
Li et al. (Feb 26, 2021). SARS-CoV-2 Viremia Is Associated with Distinct Proteomic Pathways and Predicts COVID-19 Outcomes. Pre-print downloaded Feb 26 from https://doi.org/10.1101/2021.02.24.21252357